Endovascular Intravascular Lithotripsy in the Treatment of Calcific Common Femoral Artery Disease: A Case Series With an 18-Month Follow-Up

Baig, Muhammad; Kwok, Michael; Aldairi, Ammer; Imran, Hafiz; Khan, Mohammad Saud; Moustafa, Abdelmoniem; Hyder, Omar; Saad, Marwan; Aronow, Herbert D.; Soukas, Peter

doi:10.1016/j.carrev.2022.05.003

Cited by 8 publications

(5 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Disadvantages include challenges in reimbursement and added cost, though cost-effectiveness analyses compared to open CFA revascularisation have not been performed yet. Long-term data are lacking to date [ 49 , 52 , 53 , 54 , 55 , 56 , 57 , 58 ].…”

Section: Narrative Reviewmentioning

confidence: 99%

“…Clinically driven TLR reached 80.6% in the follow-up. This did not prove to be dependent on the used adjunctive therapy, though data are limited to 54 CFA lesions [ 55 ]. The DISRUPT PAD III trial has disclosed the distribution and further analysis of treated peripheral arteries, showing that the CFA was treated in 27 patients with different adjunctive therapies.…”

Section: Narrative Reviewmentioning

confidence: 99%

See 1 more Smart Citation

Percutaneous Endovascular Reconstruction of the Common Femoral Artery and Its Bifurcation

Rassam,

Coscas

2024

JCM

View full text Add to dashboard Cite

Occlusive lesions of the common femoral artery (CFA) and its bifurcation have traditionally been treated with open surgery. Although long-term patency rates after open surgery are excellent, such repairs are associated with substantial local and general morbidity. In recent years, different treatment options have emerged within percutaneous endovascular repair. We hereby present a narrative review on endovascular treatment modalities and a treatment algorithm for endovascular revascularisation of the CFA and its bifurcation. Lesion analysis, access issues, vessel preparation tools, and types of repairs with or without the involvement of the bifurcation are described. Based on current data, an interventional approach can result in high technical success and acceptable mid-term patency rates. Further comparative evidence with open surgery and/or between the different types of endovascular repairs is required to improve the current treatment algorithm.

show abstract

Section: Narrative Reviewmentioning

confidence: 99%

Section: Narrative Reviewmentioning

confidence: 99%

Percutaneous Endovascular Reconstruction of the Common Femoral Artery and Its Bifurcation

Rassam,

Coscas

2024

JCM

View full text Add to dashboard Cite

show abstract

“…Studies have shown utility both as a primary treatment approach and in the vessel preparation for either DCB or stent placement. [13][14][15][16] The DISRUPT PAD trial data show the safety and efficacy of low-pressure lithotripsy balloon (Shockwave Medical Inc) angioplasty. DISRUPT data shows improved primary patency at 1 year (80.5 vs. 68.0%, p ¼ 0.017) and 2 years (70.3 vs. 51.3%, p ¼ 0.003) for vessels initially treated with IVL rather than POBA prior to DCB angioplasty.…”

Section: Angioplastymentioning

confidence: 99%

“…15 While IVL has been shown effective in peripheral arterial interventions, data regarding its use in CFAD are limited. 13,14 Use of IVL in the common femoral artery has shown luminal gains averaging near 3 mm, with most cases demonstrating less than 30% residual stenosis, and overall low complication rates including embolization, perforation, and occlusion. 13,14 The majority of cases of IVL for treatment of common femoral disease remain focused on vessel preparation for DCB, atherectomy, or stenting as an adjunct treatment.…”

Section: Angioplastymentioning

confidence: 99%

“…13 14 Use of IVL in the common femoral artery has shown luminal gains averaging near 3 mm, with most cases demonstrating less than 30% residual stenosis, and overall low complication rates including embolization, perforation, and occlusion. 13 14 The majority of cases of IVL for treatment of common femoral disease remain focused on vessel preparation for DCB, atherectomy, or stenting as an adjunct treatment. While early results show promise, mid- and long-term data remain elusive limiting conclusions on its role compared to surgical endarterectomy.…”

Section: Endovascular Managementmentioning

confidence: 99%

See 1 more Smart Citation

Surgical, Endovascular, and Multimodal Approaches to the Management of Atherosclerotic Common Femoral Artery Disease

Kugler

2023

Semin intervent Radiol

View full text Add to dashboard Cite

Common femoral artery disease is at the heart of nearly all treatment algorithms and decisions for patients with symptomatic peripheral arterial disease. Surgical endarterectomy has been the mainstay of common femoral treatment with a wealth of data supporting its safety, efficacy, and durability. Advances in endovascular technology and techniques for the management of iliac and superficial femoral artery disease has resulted in a paradigm shift in management. The common femoral artery has been aptly named a “no stent zone” due to anatomic and disease-specific challenges that have limited the role for endovascular techniques. New technology and techniques in the endovascular management of common femoral disease seek to change our treatment strategies. A multimodal approach utilizing a combination of angioplasty, atherectomy, and stenting has been shown most beneficial, although limited long-term data leave durability an unanswered question. While surgical treatment remains the gold standard, advances in the endovascular approach will certainly continue to improve outcomes. As truly isolated common femoral disease is a rarity, a collaborative approach combining all benefits of open and endovascular techniques in the treatment of peripheral arterial disease is essential.

show abstract

Endovascular Treatment of Calcific Common Femoral Artery Disease – The Future or Even Present

Koifman

Ela

2022

Cardiovascular Revascularization Medicine

View full text Add to dashboard Cite

Endovascular Intravascular Lithotripsy in the Treatment of Calcific Common Femoral Artery Disease: A Case Series With an 18-Month Follow-Up

Cited by 8 publications

References 25 publications

Percutaneous Endovascular Reconstruction of the Common Femoral Artery and Its Bifurcation

Percutaneous Endovascular Reconstruction of the Common Femoral Artery and Its Bifurcation

Surgical, Endovascular, and Multimodal Approaches to the Management of Atherosclerotic Common Femoral Artery Disease

Endovascular Treatment of Calcific Common Femoral Artery Disease – The Future or Even Present

Contact Info

Product

Resources

About